{
  "symbol": "BIIB",
  "company_name": "Biogen Inc",
  "ir_website": "https://investors.biogen.com/",
  "structured_data": [
    {
      "section_name": "News Articles",
      "links": [
        {
          "title": "“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched  in South Korea",
          "url": "https://investors.biogen.com/news/news-release-details/leqembir-lecanemab-treatment-alzheimers-disease-launched-south",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nPage Not Found\n\n# Page Not Found\n\n![](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/BiogenLogo_GlassWall_img1.jpeg)\n\n# Page Not Found\n\nWe are sorry, the page you requested cannot be found. Please check the URL or visit our [Homepage](/).\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n\n![Cookiebot session tracker icon loaded](https://imgsct.cookiebot.com/1.gif?dgi=83f5bab8-6928-4b5a-97c8-be5b3a0e03bb)\n"
        },
        {
          "title": "Biogen to Participate in the 7th Annual Evercore HealthCONx Conference",
          "url": "https://investors.biogen.com/news/news-release-details/biogen-participate-7th-annual-evercore-healthconx-conference",
          "content": "Cookies\n\nThis website uses cookies to improve the site and your experience. By continuing to browse the site, you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, you can modify your browser settings appropriately, or you may visit our cookies page.\n\n[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nPage Not Found\n\n# Page Not Found\n\n![](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/BiogenLogo_GlassWall_img1.jpeg)\n\n# Page Not Found\n\nWe are sorry, the page you requested cannot be found. Please check the URL or visit our [Homepage](/).\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n\n![Cookiebot session tracker icon loaded](https://imgsct.cookiebot.com/1.gif?dgi=83f5bab8-6928-4b5a-97c8-be5b3a0e03bb)\n"
        },
        {
          "title": "Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity",
          "url": "https://investors.biogen.com/news/news-release-details/dapirolizumab-pegol-phase-3-data-presented-american-college",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nPage Not Found\n\n# Page Not Found\n\n![](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/BiogenLogo_GlassWall_img1.jpeg)\n\n# Page Not Found\n\nWe are sorry, the page you requested cannot be found. Please check the URL or visit our [Homepage](/).\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n"
        },
        {
          "title": "Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™",
          "url": "https://investors.biogen.com/news/news-release-details/samsung-bioepis-and-biogen-receive-european-commission-ec",
          "content": "Cookies\n\nThis website uses cookies to improve the site and your experience. By continuing to browse the site, you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, you can modify your browser settings appropriately, or you may visit our cookies page.\n\n[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nPage Not Found\n\n# Page Not Found\n\n![](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/BiogenLogo_GlassWall_img1.jpeg)\n\n# Page Not Found\n\nWe are sorry, the page you requested cannot be found. Please check the URL or visit our [Homepage](/).\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n\n![Cookiebot session tracker icon loaded](https://imgsct.cookiebot.com/1.gif?dgi=83f5bab8-6928-4b5a-97c8-be5b3a0e03bb)\n"
        }
      ]
    },
    {
      "section_name": "Events & Presentations",
      "links": [
        {
          "title": "Biogen at the 7th Annual Evercore HealthCONx Conference",
          "url": "https://investors.biogen.com/events/event-details/biogen-7th-annual-evercore-healthconx-conference",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nEvents & Presentations\n\n# Event Details\n\n![](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/BiogenLogo_GlassWall_img1.jpeg)\n\n## Biogen at the 7th Annual Evercore HealthCONx Conference\n\nDec 3, 2024 9:10 AM EST\n\n[Listen to webcast](https://wsw.com/webcast/evercore44/biib/2320290)\n\n[Add to Outlook](/node/28611/ics)\n\n[Add to Google Calendar](https://www.google.com/calendar/render?action=TEMPLATE&text=Biogen - Biogen at the 7th Annual Evercore HealthCONx Conference&dates=20241203T141000Z/20241203T141000Z&details=Event Details: https://investors.biogen.com/events/event-details/biogen-7th-annual-evercore-healthconx-conference%0A%0AWebcast: https://wsw.com/webcast/evercore44/biib/2320290&location=&trp=false&sprop=&sprop=name:)\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n"
        },
        {
          "title": "Q3 2024 Earnings Call Webcast",
          "url": "https://investors.biogen.com/events/event-details/q3-2024-earnings-call-webcast",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nEvents & Presentations\n\n# Event Details\n\n![](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/BiogenLogo_GlassWall_img1.jpeg)\n\n## Q3 2024 Earnings Call Webcast\n\nOct 30, 2024 8:30 AM EDT\n\n[Listen to webcast](https://event.webcasts.com/starthere.jsp?ei=1681331&tp_key=17a2343afa)\n\n### Supporting Materials\n\n[Biogen Reports Third Quarter 2024 Results](/static-files/75f1044b-a254-48e9-acdb-bcb0263930b0 \"Biogen Q324 Earnings Press Release FINAL with Tables.pdf\") 465.4 KB\n\n[Q3 2024 Biogen Earnings Presentation](/static-files/240910c8-9181-4870-b85c-c036568487c0 \"Biogen Q324 Earnings Presentation FINAL.pdf\") 2.1 MB\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n"
        },
        {
          "title": "Biogen at the Cantor Fitzgerald Global Healthcare Conference",
          "url": "https://investors.biogen.com/events/event-details/biogen-cantor-fitzgerald-global-healthcare-conference",
          "content": "Cookies\n\nThis website uses cookies to improve the site and your experience. By continuing to browse the site, you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, you can modify your browser settings appropriately, or you may visit our cookies page.\n\n[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nEvents & Presentations\n\n# Event Details\n\n![](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/BiogenLogo_GlassWall_img1.jpeg)\n\n## Biogen at the Cantor Fitzgerald Global Healthcare Conference\n\nSep 18, 2024 1:20 PM EDT\n\n[Listen to webcast](https://wsw.com/webcast/cantor22/register.aspx?conf=cantor22&page=biib&url=https%3A//wsw.com/webcast/cantor22/biib/2045970)\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n\n![Cookiebot session tracker icon loaded](https://imgsct.cookiebot.com/1.gif?dgi=83f5bab8-6928-4b5a-97c8-be5b3a0e03bb)\n"
        },
        {
          "title": "Biogen at the Morgan Stanley 22nd Annual Global Healthcare Conference",
          "url": "https://investors.biogen.com/events/event-details/biogen-morgan-stanley-22nd-annual-global-healthcare-conference",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nEvents & Presentations\n\n# Event Details\n\n![](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/BiogenLogo_GlassWall_img1.jpeg)\n\n## Biogen at the Morgan Stanley 22nd Annual Global Healthcare Conference\n\nSep 4, 2024 10:00 AM EDT\n\n[Listen to webcast](https://event.webcasts.com/starthere.jsp?ei=1683482&tp_key=90c9283e31&tp_special=8)\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "View Annual Report",
          "url": "https://investors.biogen.com/financials/annual-reports",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nFinancials\n\n# Annual Reports\n\n![View of a building](/system/files-encrypted/nasdaq_kms/inline-images/og-financials-inv.jpg)\n\n## Our Annual Reports\n\n[ ![2023 Annual Report](/static-files/e95828f3-9658-4392-aea8-3799290142be ) ](/static-files/2e9fd886-9ed5-443c-b6dc-00f5e7611d9e )\n\n2023 Annual Report\n\n[](/static-files/2e9fd886-9ed5-443c-b6dc-00f5e7611d9e )\n\n[ ![2022 Annual Report](/static-files/0a8d3063-1645-4fd8-9446-89533bc838f3 ) ](/static-files/4dbbe840-0b25-412e-a681-b9b0428b6a5e )\n\n2022 Annual Report\n\n[](/static-files/4dbbe840-0b25-412e-a681-b9b0428b6a5e )\n\n[ ![2021 Annual Report](/static-files/9bcb9750-8f50-4917-a39a-2a663ba4d65d ) ](/static-files/316c17ed-0bff-458c-9204-5d38e65e3526 )\n\n2021 Annual Report\n\n[](/static-files/316c17ed-0bff-458c-9204-5d38e65e3526 )\n\n[ ![2020 Annual Report](/static-files/cae5b980-4a33-4567-bcb1-2604db5a5cf8 ) ](/static-files/0b109c48-3d3c-4554-8249-74b06c09797e )\n\n2020 Annual Report\n\n[](/static-files/0b109c48-3d3c-4554-8249-74b06c09797e )\n\n[ ![2019 Annual Report](/static-files/ca815b14-25ec-417c-8723-41378dfb3fed ) ](/static-files/f86236ee-b489-461e-bb28-b7b4ccc4aeea )\n\n2019 Annual Report\n\n[](/static-files/f86236ee-b489-461e-bb28-b7b4ccc4aeea )\n\n[ ![2018 Annual Report](/static-files/78795cb4-1af8-43f2-be99-31aadaf0ed61 ) ](/static-files/30ea6b55-6a57-48ae-840d-96ac58ddf031 )\n\n2018 Annual Report\n\n[](/static-files/30ea6b55-6a57-48ae-840d-96ac58ddf031 )\n\n[ ![2017 Annual Report](/static-files/b7681a35-c8be-4b14-b261-226b99185646 ) ](/static-files/8cb6d155-963c-4282-83ca-013b642b341f )\n\n2017 Annual Report\n\n[](/static-files/8cb6d155-963c-4282-83ca-013b642b341f )\n\n[ ![2016 Annual Report](/static-files/3787b279-8e42-494e-ac08-5d0ea15abc1e ) ](/static-files/8eb889d1-6c53-4970-a088-097ebead3bc5 )\n\n2016 Annual Report\n\n[](/static-files/8eb889d1-6c53-4970-a088-097ebead3bc5 )\n\n[ ![2015 Annual Report](/static-files/1a2eaa24-5bcc-4512-aa46-14b60a227617 ) ](/static-files/8ec522bd-82b6-4a2f-9ec1-7bef61f5472a )\n\n2015 Annual Report\n\n[](/static-files/8ec522bd-82b6-4a2f-9ec1-7bef61f5472a )\n\n[ ![2014 Annual Report](/static-files/541155d6-9ea7-4ca3-8b56-7ae7acb19083 ) ](/static-files/f57e4b1b-9f81-46f8-b6c3-8fe449055117 )\n\n2014 Annual Report\n\n[](/static-files/f57e4b1b-9f81-46f8-b6c3-8fe449055117 )\n\n[ ![2013 Annual Report](/static-files/bf7b350b-f165-409a-b198-40414faa7ffa ) ](/static-files/8ce76fda-4f2c-4bf9-85fc-6a7532865fef )\n\n2013 Annual Report\n\n[](/static-files/8ce76fda-4f2c-4bf9-85fc-6a7532865fef )\n\n[ ![2012 Annual Report](/static-files/fb122579-dc38-4b42-aa04-ed2755fb18a1 ) ](/static-files/e9d0380b-3e7e-4f65-8070-a4f45813e00f )\n\n2012 Annual Report\n\n[](/static-files/e9d0380b-3e7e-4f65-8070-a4f45813e00f )\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n"
        },
        {
          "title": "View All SEC Filings",
          "url": "https://investors.biogen.com/financials/sec-filings",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Biogen colored logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen-logo-colour.svg) ![Biogen white logo](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/biogen_logo_white.svg) ](https://www.biogen.com/)\n\n[](#)\n\nFinancials\n\n# SEC Filings\n\n![View of a building](/system/files-encrypted/nasdaq_kms/inline-images/og-financials-inv.jpg)\n\nGroup All 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements\n\nFiling year All 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996\n\n[Filing Date](?items_per_page=10&order=field_nir_sec_date_filed&sort=asc \"Sort By Filing Date\") | [Description](?items_per_page=10&order=field_nir_sec_description&sort=asc \"Sort By Description\") | [Form](?items_per_page=10&order=field_nir_sec_form&sort=asc \"Sort By Form\") | View  \n---|---|---|---  \nNov 12, 2024 |  An amendment to the SC 13G filing |  [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0000932471-24-000849) |  [0000932471-24-000849.pdf](/static-files/b605ac09-fea5-4f40-99af-97fb77f6531c) [0000932471-24-000849.rtf](/static-files/74c1dd12-a085-483d-8844-db3e7c1c3f3e) [View HTML](/node/28581/html)  \nNov 07, 2024 |  Statement of changes in beneficial ownership of securities |  [4](/sec-filings/sec-filing/4/0001127602-24-026727) |  [0001127602-24-026727.pdf](/static-files/c9ff3277-60cd-4290-a37e-15e38c9ce33e) [0001127602-24-026727.rtf](/static-files/e9536195-8a1f-4ec1-b4a4-d23944b7f290) [0001127602-24-026727.xls](/static-files/2191e018-43bd-45e6-b73b-1479c0dd4284) [View HTML](/node/28571/html)  \nNov 07, 2024 |  An amendment to the SC 13G filing |  [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0001193125-24-253265) |  [0001193125-24-253265.pdf](/static-files/7a1409d7-59ab-4c43-a325-720263114ce9) [0001193125-24-253265.rtf](/static-files/37760049-0d2e-44b5-bcb6-ef3cd9ba0f15) [View HTML](/node/28576/html)  \nNov 04, 2024 |  An amendment to the SC 13G filing |  [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0000932471-24-000309) |  [0000932471-24-000309.pdf](/static-files/921152a0-c9d6-48f5-91ca-2d4fb84b4712) [0000932471-24-000309.rtf](/static-files/410a4219-5bce-463a-8c6f-72f27dd83dc4) [View HTML](/node/28561/html)  \nNov 04, 2024 |  Statement of changes in beneficial ownership of securities |  [4](/sec-filings/sec-filing/4/0001127602-24-026385) |  [0001127602-24-026385.pdf](/static-files/455fc20c-20c7-4eac-92a0-c214764664dc) [0001127602-24-026385.rtf](/static-files/1b92438c-89ac-4a33-bbd2-f726e287d745) [0001127602-24-026385.xls](/static-files/e4ad4cd3-1966-49ea-9349-8fdb14837eb5) [View HTML](/node/28566/html)  \nOct 30, 2024 |  Report of unscheduled material events or corporate event |  [8-K](/sec-filings/sec-filing/8-k/0000875045-24-000030) |  [0000875045-24-000030.pdf](/static-files/dd0eca60-db52-4d66-8816-bd9a7d3a1f01) [0000875045-24-000030.rtf](/static-files/50dd1220-241c-41d4-9867-d45fc5acfa65) [0000875045-24-000030.xls](/static-files/3f0a0073-6070-42d2-934c-dcfa3132f74d) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0000875045-24-000030) [View HTML](/node/28531/html)  \nOct 30, 2024 |  Quarterly report which provides a continuing view of a company's financial position |  [10-Q](/sec-filings/sec-filing/10-q/0000875045-24-000032) |  [0000875045-24-000032.pdf](/static-files/7e0c5ba7-737b-4788-b036-2cd4401378b3) [0000875045-24-000032.rtf](/static-files/ee83c1b2-35d1-4b1c-acc7-74098758005e) [0000875045-24-000032.xls](/static-files/90a05ffb-9c83-4327-9808-d2e4fb09774e) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0000875045-24-000032) [View HTML](/node/28536/html)  \nOct 30, 2024 |  Report of unscheduled material events or corporate event |  [8-K](/sec-filings/sec-filing/8-k/0001193125-24-247628) |  [0001193125-24-247628.pdf](/static-files/b28cc62a-2c62-41b0-bb91-fef141567aba) [0001193125-24-247628.rtf](/static-files/40475634-b68f-49ff-b442-b6fad4e4a08c) [0001193125-24-247628.xls](/static-files/fa792065-13bd-45e6-a094-93f2ba9dd221) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0001193125-24-247628) [View HTML](/node/28541/html)  \nOct 16, 2024 |  A statement of beneficial ownership of common stock by certain persons |  [SC 13G](/sec-filings/sec-filing/sc-13g/0000093751-24-000752) |  [0000093751-24-000752.pdf](/static-files/13566640-14f3-4c56-b4fe-1151150fcc7e) [0000093751-24-000752.rtf](/static-files/b3bba2b1-d882-44f4-b8de-086e9454799e) [0000093751-24-000752.xls](/static-files/7c964136-7dd0-4a25-90c7-54935fce6f99) [View HTML](/node/28441/html)  \nOct 07, 2024 |  Initial filing by director officer or owner of more than ten percent |  [3](/sec-filings/sec-filing/3/0001127602-24-025309) |  [0001127602-24-025309.pdf](/static-files/304c9f79-1207-4e7e-9ce5-8be2c19733a9) [0001127602-24-025309.rtf](/static-files/899d45fd-e42e-4191-ac6f-6a40fa2c291c) [0001127602-24-025309.xls](/static-files/4535e06f-2b99-4cbf-b8fe-6802dee7fcc6) [View HTML](/node/28416/html)  \n  \nData provided by [Kaleidoscope](https://www.kscope.io).\n\n![Stockholder Communications icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/stockholder.svg)\n\n**Stockholder Communications**\n\n[](/governance/contact-the-board)\n\n![E-mail Alerts icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/email-alerts.svg)\n\n**E-mail Alerts**\n\n[](/sign-up-for-alerts)\n\n![FAQs icon](/sites/g/files/knoqqb90876/themes/site/client_site_202/dist/images/faqs.svg)\n\n**FAQs**\n\n[](/stock-information/investor-faqs)\n\n[Learn more about our Events & Presentations](/events-presentations/events)\n\n[](/events-presentations/events)\n"
        }
      ]
    }
  ]
}